BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Intracranial Coil-Assist Stent

    PMA: P170013 · Supplement: S004 · Decision Jul 28, 2022
    View on FDA
    Classifications
    1
    FEI Numbers
    6
    Registration Numbers
    6

    Basic Information

    Device Name
    Intracranial Coil-Assist Stent
    Trade Name
    Low-Profile Visualized Intraluminal Support (LVIS), LVIS Jr., LVIS EVO
    PMA Number
    P170013
    Supplement Number
    S004
    Device Class
    FDA Class 3
    Product Code
    QCA
    Generic Name
    Intracranial coil-assist stent
    Medical Specialty
    Unknown
    Advisory Committee
    Neurology
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    July 28, 2022
    Date Received
    March 12, 2021
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    Approval for the new Low-Profile Visualized Intraluminal Support (LVIS) EVO. The LVIS EVO has a modified design compared to the approved LVIS and LVIS Jr. with a change in the radiopacity profile and shorter flared ends of the stent.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    QCA Intracranial Coil-Assist Stent